Title of article
Bilateral Cystoid Macular Edema Secondary to Paclitaxel Treatment
Author/Authors
Tezcan, Yilmaz N. E. U. - Department of Radiation Oncology - Meram Faculty of Medicine , Surmeli, Mustafa N. E. U. - Department of Radiation Oncology - Meram Faculty of Medicine , Tastekin, Didem I. U. - Department of Medical Oncology - Istanbul Faculty of Medicine , Koc, Mehmet N. E. U. - Department of Radiation Oncology - Meram Faculty of Medicine
Pages
2
From page
606
To page
607
Abstract
Cystoid macular edema is rarely observed secondary to paclitaxel treatment. A 55-year-old female patient was applied five cures of paclitaxel and carboplatin chemotherapy after being diagnosed with metastatic ovarian cancer. The patient had a normal bilateral vision prior to the chemotherapy treatments. After the fifth cure, the patient complained of bilateral vision loss, which was more severe in the left eye. Ophthalmologic examination revealed that right eye vision was 4/10 blurred without glasses and 7/10 blurred with glasses, left eye vision was 1/10 blurred without glasses and 4/10 blurred with glasses. Pathology was not detected during the biomicroscopic examination. Fundus examination of the patient revealed pigment epithelium irregularity, which was found to be less in the right eye, and it was found a decrease in foveal cavity. For fundus examination, the patient underwent fundus fluorescein angiography (FFA) and optical coherence tomography (OCT). FFA revealed fluorescein leakage and cystoid appearance particularly more apparent in the left eye. Thickening in the macula and cystoid space was observed particularly more in the left eye in the OCT measurement. In conclusion, we presented our case as a rarely observed cystoid macular edema secondary to paclitaxel treatment.
Keywords
paclitaxel , ovarian cancer , cystoid macular edema , Chemotherapy
Journal title
Astroparticle Physics
Serial Year
2015
Record number
2423525
Link To Document